Taofeek Kunle Owonikoko (Taofeek K Owonikoko)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 26

Top Topics

Metastatic Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, Mehmet A Bilen, Taofeek Kunle Owonikoko, Jonathan L Kaufman, Ajay K Nooka, Colleen M Lewis, Elise Hitron, Hannah Collins, Emma C Judson, Olatunji B Alese, Robert Donald Harvey, Jennifer Wilkinson Carlisle
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast. The oncologist (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Asmi Chattaraj, Masood Pasha Syed, Carissa A Low, Taofeek Kunle Owonikoko
Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies. JCO oncology practice (2023)
Guangzhi Ma, Yunfu Deng, Luxi Qian, Karin A Vallega, Guojing Zhang, Xingming Deng, Taofeek Kunle Owonikoko, Suresh S Ramalingam, Douglas D Fang, Yifan Zhai, Shi-Yong Sun
Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both. Oncogene 41 (12) (2022)
Bassel Nazha, Chao Zhang, Zhengjia Chen, Camille Ragin, Taofeek Kunle Owonikoko
Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis. Cancers 14 (13) (2022)
Julie E Bauman, Zhengjia Chen, Chao Zhang, James P Ohr, Robert L Ferris, Gerald M McGorisk, Stephen Brandt, Sumathi Srivatsa, Amy Y Chen, Conor E Steuer, Dong M Shin, Nabil F Saba, Fadlo R Khuri, Taofeek Kunle Owonikoko
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer. Cancers 14 (11) (2022)
Yoon-Koo Kang, Martin Reck, Paul T Nghiem, Yan Feng, Gregory Plautz, Hye Ryun Kim, Taofeek Kunle Owonikoko, Narikazu Boku, Li-Tzong Chen, Ming Lei, Han Chang, Wen Hong Lin, Amit Roy, Akintunde Bello, Jennifer Sheng
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. Journal for immunotherapy of cancer 10 (4) (2022)
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, Richard J Lee, Melinda L Telli, Alice C Fan, Angela M DeMichele, Naomi B Haas, Manish R Patel, James J Harding, Martin H Voss, Taofeek Kunle Owonikoko, Bradley Carthon, Ramaprasad Srinivasan, Johanna C Bendell, Yonchu Jenkins, Sam H Whiting, Keith Orford, Mark K Bennett, Todd M Bauer
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Matthew R Kudelka, Yi Lasanajak, David F Smith, Xuezheng Song, Mohammad S Hossain, Taofeek Kunle Owonikoko
Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer. Cancer medicine (2022)
Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, Jared M Weiss, Taofeek Kunle Owonikoko, Julie A Rytlewski, Jill Hood, Zhao Yang, Rajesh K Malik, Jay C Strum, Patrick J Roberts
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Lei Zhu, Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang, Kevin D-Y Sun, Qiming Wang, Yong He, Taofeek Kunle Owonikoko, Suresh R Ramalingam, Shi-Yong Sun
Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib. Cancer research 81 (18) (2021)
Taofeek Kunle Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez-Cid, Michael Schenker, Jong-Seok Lee, Vanesa Gutierrez, Ivor Percent, Daniel Morgensztern, Carlos Henrique Barrios, Laurent Greillier, Sofia Baka, Miten Patel, Wen Hong Lin, Giovanni Selvaggi, Christine Baudelet, Jonathan Baden, Dimple Pandya, Parul Doshi, Hye Ryun Kim
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Guoqing Qian, Jianping Guo, Karin A Vallega, Changjiang Hu, Zhen Chen, Yunfu Deng, Qiming Wang, Songqing Fan, Suresh R Ramalingam, Taofeek Kunle Owonikoko, Wenyi Wei, Shi-Yong Sun
Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors. Molecular cancer research : MCR 19 (10) (2021)
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, ChoonHee Son, Anne Sibille, Taofeek Kunle Owonikoko, Harry J M Groen, Carl M Gay, Junya Fujimoto, Patricia M de Groot, Martin Dunbar, Kingston Kang, Lei He, Vasudha Sehgal, Jaimee Glasgow, Bruce Allen Bach, Peter Michael Ellis
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Suchita Pakkala, Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor Steuer, Chao Zhang, Guojing Zhang, Shuhua Wang, Mohammad S Hossain, Bassel Nazha, Tyler Beardslee, Fadlo R Khuri, Walter Curran, Sagar Lonial, Edmund K Waller, Suresh Ramalingam, Taofeek Kunle Owonikoko
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study. Journal for immunotherapy of cancer 8 (2) (2021)
Zhen Chen, Danlei Yu, Taofeek Kunle Owonikoko, Suresh S Ramalingam, Shi-Yong Sun
Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib. Oncogene 40 (49) (2021)
Bassel Nazha, James Chih-Hsin Yang, Taofeek Kunle Owonikoko
Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer. Future oncology (London, England) 17 (8) (2020)
Dong M Shin, Sreenivas Nannapaneni, Mihir R Patel, Qiuying Shi, Yuan Liu, Zhengjia Chen, Amy Y Chen, Mark W El-Deiry, Jonathan J Beitler, Conor E Steuer, Steven M Roser, Adam M Klein, Taofeek Kunle Owonikoko, Suresh S Ramalingam, Fadlo R Khuri, Zhuo G Chen, Nabil F Saba
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Bassel Nazha, Subir Goyal, Zhengjia Chen, Anne Engelhart, Jennifer Wilkinson Carlisle, Tyler J Beardslee, Harpaul Gill, Levani Odikadze, Yuan Liu, Manoj K Mishra, Suresh R Ramalingam, Taofeek Kunle Owonikoko
Efficacy and safety of immune checkpoint blockade in self-identified Black patients with advanced non-small cell lung cancer. Cancer 126 (23) (2020)
Jennifer Wilkinson Carlisle, Conor E Steuer, Taofeek Kunle Owonikoko, Nabil F Saba
An update on the immune landscape in lung and head and neck cancers. CA: a cancer journal for clinicians 70 (6) (2020)
Portia L Thomas, Chioma J Madubata, Melinda C Aldrich, Montessa M Lee, Taofeek Kunle Owonikoko, John D Minna, Charles M Rudin, Julien Sage, Christine M Lovly
A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer. Cancer discovery 11 (2) (2020)
R Donald Harvey, Bradley C Carthon, Colleen Lewis, Mohammad S Hossain, Chao Zhang, Zhengjia Chen, Wayne B Harris, Olatunji B Alese, Walid Shaib, Mehmet A Bilen, David H Lawson, Christina Wu, Conor E Steuer, Bassel F El-Rayes, Fadlo R Khuri, Sagar Lonial, Edmund K Waller, Suresh S Ramalingam, Taofeek Kunle Owonikoko
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British journal of cancer 123 (8) (2020)
Taofeek Kunle Owonikoko, Guojing Zhang, Shenila B Lallani, Zhengjia Chen, Deborah E Martinson, Fadlo R Khuri, Sagar Lonial, Adam Marcus, Shi-Yong Sun
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models. PloS one 14 (2) (2019)
Sibo Tian, Jeffrey M Switchenko, Teng Fei, Robert H Press, Mustafa Abugideiri, Nabil F Saba, Taofeek Kunle Owonikoko, Amy Y Chen, Jonathan J Beitler, Walter J Curran, Theresa W Gillespie, Kristin A Higgins
Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups. Head & neck 42 (4) (2019)
Taofeek Kunle Owonikoko, Guojing Zhang, Hyun S Kim, Renea M Stinson, Rabih Bechara, Chao Zhang, Zhengjia Chen, Nabil F Saba, Suchita Pakkala, Rathi Pillai, Xingming Deng, Shi-Yong Sun, Michael R Rossi, Gabriel L Sica, Suresh S Ramalingam, Fadlo R Khuri
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of translational medicine 14 (1) (2016)